The effect of eight weeks of high-intensity interval swimming on hepatic shbg protein levels and glycemic control variables in high-fat diet-fed male rats

Document Type : Original Article

Authors

1 Assistant Professor at Department of Sports Sciences, Faculty of Humanities, University of Hormozgan, Bandar Abbas, Iran.

2 PhD in Exercise Physiology, Faculty of Psychology and Educational Sciences, Shiraz University, Shiraz, Iran.

Abstract

Extended Abstract 
Background and Aim: Non-alcoholic fatty liver disease (NAFLD) and its advanced form, non-alcoholic steatohepatitis (NASH), have been rapidly increased in prevalence worldwide, including in Iran. These hepatic metabolic disorders are associated with an elevated risk of cardiovascular mortality, type 2 diabetes, and other metabolic comorbidities. Hepatokines such as sex hormone-binding globulin (SHBG), beyond their hormonal regulatory functions, have been identified as sensitive biomarkers for the diagnosis of NASH and glycemic disturbances. Recent studies suggest that SHBG concentrations are inversely related to steatosis severity and insulin resistance, lifestyle modifications and physical activity—particularly high-intensity interval training (HIIT)- can enhance SHBG levels. Therefore, the aim of this study was to evaluate the effects of eight weeks of HIIT swimming on hepatic SHBG protein levels and selected glycemic control variables in a rat model of NASH induced by a high-fat diet.
Materials and Methods: This experimental study was conducted on 40 male Sprague-Dawley rats (6-8 weeks old, weighing 230±20 g). The animals were randomly assigned to four groups: healthy-control, exercise-healthy, control-patient, and exercise-patient. To induce NASH, the patient groups were fed a high-fat diet for eight weeks. Following confirmation the induction of the disease through macroscopic, microscopic, and biochemical assessments, the exercise intervention was initiated. The exercise groups underwent a HIIT swimming protocol consisting of 20 × 30-second swim bouts, each followed by 30 seconds of rest, with a weight attached to the tail. The HIIT was conducted three times per week for eight weeks. Exercise intensity progressed from 7% of body weight in the first week to 14% by the eighth week.
Forty-eight hours after the final exercise session, blood and liver tissue samples were collected. SHBG protein levels were measured via Western blot, serum insulin was assessed using ELISA, and fasting blood glucose was determined using a photometric method. Insulin resistance was calculated using the HOMA-IR formula.
During the study, animal housing conditions (temperature 22-24°C, humidity 45%, dark-light cycle 12:12) and free access to water and food were observed. To reduce animal stress, a familiarization phase with the pool and training environment was performed two weeks prior to the intervention. Data were analyzed using one-way analysis of variance and Bonferroni post hoc test at a significance level of p<0.05.
Findings: Pathological, biochemical, and macroscopic changes characteristic of NASH were observed in rats. Macroscopically, the livers of the diseased groups appeared pale and swollen compared to the smooth, reddish livers of the healthy groups. Microscopic observations with H&E and Oil Red O staining revealed marked steatosis, inflammation, and extensive fat accumulation in the livers of the diseased animals, consistent with established NASH pathology and previous studies. Biochemical assays showed significantly increased levels of alanine aminotransferase (ALT) and aspartate transaminase (AST) enzymes in diseased groups versus healthy controls, confirming hepatocellular injury and successful disease induction. Hepatic sex hormone-binding globulin (SHBG) protein was highest in the healthy -control group, while significantly reduced in control-patient (p=0.001) and exercise-patient (p=0.002) groups when compared to healthy controls. Still, the exercise-patient group showed a non-significant upward trend in SHBG compared to control-patient. Fasting blood glucose was significantly reduced in the exercise-patient group compared to control-patient (p=0.001), indicating improved glycemic regulation through HIIT swimming. Although insulin and HOMA-IR values were lower in the NASH exercise group compared to the NASH control group, the differences were not statistically significant (p=0.14).
In terms of body weight, the healthy exercise group exhibited a significant reduction compared to both the healthy control (p=0.003) and NASH control (p=0.002) groups. The NASH exercise group also showed a non-significant downward trend in body weight compared to the NASH control group (Table 1).
Conclusion: The findings of this study clearly demonstrate that eight weeks of HIIT swimming significantly reduced fasting blood glucose and prevented further declines in hepatic SHBG levels in a diet-induced NASH rat model. Although changes in insulin resistance were not statistically significant, a downward trend was observed, reflecting the exercise’s potential for beneficial impact. Given the prognostic value of SHBG in liver pathology and type 2 diabetes, the present results underscore the capacity of HIIT to modulate metabolic disorders and possibly exert direct regulative effects on hepatic molecular dynamics. Additionally, aquatic environments may minimize injury risk and inflammation, making swimming particularly suitable for metabolically impaired subjects. In summary, sustained high-intensity exercise—even in the absence of dietary restriction—can play a crucial role in managing NAFLD/NASH. Further research is warranted to explore the underlying mechanisms and long-term effects of such interventions.
Ethical Considerations: This study was approved by the Research Ethics Committee of Shiraz University of Medical Sciences (Code: IR.SUMS.REHAB.REC.1400.008). All experimental procedures were conducted in accordance with institutional guidelines for the care and use of laboratory animals.
Compliance with Ethical Guidelines: The research adhered to the ethical standards of the Declaration of Helsinki and institutional guidelines. Participation was voluntary, and confidentiality of data was maintained at all stages.
Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 
Conflicts of Interest: The authors declare no conflicts of interest regarding the publication of this study.

Keywords


1. Henry L, Paik J, Younossi ZM. The epidemiologic burden of non‐alcoholic fatty liver disease across the world. Alimentary pharmacology & therapeutics. 2022;56(6):942-56. https://doi.org/10.1111/apt.17158
2. Rinella ME, Sanyal AJ. Management of NAFLD: a stage-based approach. Nature Reviews Gastroenterology & Hepatology. 2016;13(4):196-205.  https://doi.org/10.1038/nrgastro.2016.3
3. Meex RC, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nature Reviews Endocrinology. 2017;13(9):509-20. https://doi.org/10.1038/nrendo.2017.56
4. Ye J, Yao Z, Tan A, Gao Y, Chen Y, Lin X, He R, Tang R, Hu Y, Zhang H, Yang X. Low serum sex hormone-binding globulin associated with insulin resistance in men with nonalcoholic fatty liver disease. Hormone and Metabolic Research. 2017;49(05):359-64. https://doi.org/10.1055/s-0043-102690
5. Alinezhad A, Jafari F. The relationship between components of metabolic syndrome and plasma level of sex hormone-binding globulin. European Journal of Translational Myology. 2019;29(2):8196. https://doi.org/10.4081/ejtm.2019.8196
6. Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, Ouyang P, Vaidya D. Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis. Clinical Gastroenterology and Hepatology. 2015;13(9):1686-93. https://doi.org/10.1016/j.cgh.2014.12.033
7. Hua X, Li M, Pan F, Xiao Y, Cui W, Hu Y. Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients. Scientific Reports. 2017;7(1):14532. https://doi.org/10.1038/s41598-017-15232-9
8. Winters SJ, Gogineni J, Karegar M, Scoggins C, Wunderlich CA, Baumgartner R, Ghooray DT. Sex hormone-binding globulin gene expression and insulin resistance. The Journal of Clinical Endocrinology & Metabolism. 2014;99(12):E2780-8. https://doi.org/10.1210/jc.2014-2640
9. Hallsworth K, Adams LA. Lifestyle modification in NAFLD/NASH: facts and figures. JHEP Reports. 2019;1(6):468-79. https://doi.org/10.1016/j.jhepr.2019.10.008
10. Guturu P, Duchini A. Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity. International Journal of Hepatology. 2012;2012(1):212865. https://doi.org/10.1155/2012/212865
11. Kim D, Kim WR. Nonobese fatty liver disease. Clinical Gastroenterology and Hepatology. 2017;15(4):474-85. https://doi.org/10.1016/j.cgh.2016.08.028
12. Patten RK, McIlvenna LC, Levinger I, Garnham AP, Shorakae S, Parker AG, McAinch AJ, Rodgers RJ, Hiam D, Moreno-Asso A, Stepto NK. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial. Human Reproduction. 2022;37(5):1018-29. https://doi.org/10.1093/humrep/deac047
13. Bergamin M, Ermolao A, Tolomio S, Berton L, Sergi G, Zaccaria M. Water-versus land-based exercise in elderly subjects: effects on physical performance and body composition. Clinical Interventions in Aging. 2013:1109-17. https://doi.org/10.2147/cia.s44198
14. Mohseni-Takalloo S, Beigrezaei S, Yazdanpanah Z, Rajaie SH, Soltani S, Zohrabi T, Kaviani M, Forbes SC, Baker JS, Salehi-Abargouei A. Does exercise beneficially affect sex hormones when added to hypo-caloric diets in adults with overweight or obesity? A systematic review and meta-analysis of controlled clinical trials. European Journal of Endocrinology. 2022;186(2):285-95. https://doi.org/10.1530/eje-21-0675
15. Samadi Z, Bambaeichi E, Valiani M, Shahshahan Z. Evaluation of changes in levels of hyperandrogenism, hirsutism and menstrual regulation after a period of aquatic high intensity interval training in women with polycystic ovary syndrome. International Journal of Preventive Medicine. 2019;10(1):187. https://doi.org/10.4103/ijpvm.ijpvm_360_18
16. Kim JH, Ha MS, Ha SM, Kim DY. Aquatic exercise positively affects physiological frailty among postmenopausal women: a randomized controlled clinical trial. In Health Care. 2021;(9)4,:409. https://doi.org/10.3390/healthcare9040409
17. Omar JS, Jaradat N, Qadoumi M, Qadoumi AN. Regular swimming exercise improves metabolic syndrome risk factors: a quasi-experimental study. BMC Sports Science, Medicine and Rehabilitation. 2021;13(1):22. https://doi.org/10.1186/s13102-021-00254-8
18. Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, Zhang L, Wang Y. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sciences. 2006;79(11):1100-7. https://doi.org/10.1016/j.lfs.2006.03.021
19. Chen B, Ma Y, Xue X, Wei J, Hu G, Lin Y. Tetramethylpyrazine reduces inflammation in the livers of mice fed a high fat diet. Molecular Medicine Reports. 2019;19(4):2561-8. https://doi.org/10.3892/mmr.2019.9928
20. Jowhari A, Daryanoosh F, Koushkie Jahromi M, Nekooeian A A. Effect of high-intensity intermittent swimming training on peroxisome proliferator-activated receptors-α and liver enzymes in non-alcoholic steatohepatitis male rats. Journal of Shahid Sadoughi University of Medical Sciences. 2023;30(10):6034-6051. [In Persian]. https://doi.org/10.18502/ssu.v30i10.11454
21. Farzanegi P, habibian M, alinejad H. The combined effect of regular aerobic exercise with garlic extract on renal apoptosis regulatory factors in aged rats with chronic kidney disease. Journal of Arak University of Medical Sciences. 2016;19(3):62-70. [In Persian]. http://jams.arakmu.ac.ir/article-1-4153-en.html
22. Ramos-Filho D, Chicaybam G, de-Souza-Ferreira E, Guerra Martinez C, Kurtenbach E, Casimiro-Lopes G, Galina A. High intensity interval training (HIIT) induces specific changes in respiration and electron leakage in the mitochondria of different rat skeletal muscles. PloS One. 2015;10(6):e0131766. https://doi.org/10.1371/journal.pone.0131766
23. Shafiee A, kordi M, Gaeini A, Soleimani M, Nekouei A, Hadidi V. The effect of eight week of high intensity interval training on expression of Mir-210 and EphrinA3 mrna in soleus muscle healthy male rats. Journal of Arak University of Medical Sciences. 2014;17(3):26-34. [In Persian]. http://jams.arakmu.ac.ir/article-1-2770-en.html
24. Mohammed M, Al-Habori M, Abdullateef A, Saif-Ali R. Impact of metabolic syndrome factors on testosterone and SHBG in type 2 diabetes mellitus and metabolic syndrome. Journal of Diabetes Research. 2018;2018(1):4926789. https://doi.org/10.1155/2018/4926789
25. Sylow L, Kleinert M, Richter EA, Jensen TE. Exercise-stimulated glucose uptake—regulation and implications for glycaemic control. Nature Reviews Endocrinology. 2017;13(3):133-48. https://doi.org/10.1038/nrendo.2016.162
26. Chavanelle V, Boisseau N, Otero YF, Combaret L, Dardevet D, Montaurier C, Delcros G, Peltier SL, Sirvent P. Effects of high-intensity interval training and moderate-intensity continuous training on glycaemic control and skeletal muscle mitochondrial function in db/db mice. Scientific Reports. 2017;7(1):204. https://doi.org/10.1038/s41598-017-00276-8
27. Amador M, Meza CA, McAinch AJ, King GA, Covington JD, Bajpeyi S. Exercise-induced improvements in insulin sensitivity are not attenuated by a family history of type 2 diabetes. Frontiers in Endocrinology. 2020;13(11):120. https://doi.org/10.3389/fendo.2020.00120
28. Hesselink MK, Schrauwen-Hinderling V, Schrauwen P. Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus. Nature Reviews Endocrinology. 2016;12(11):633-45. https://doi.org/10.1038/nrendo.2016.104
29. Antonio L, Wu FC, O’Neill TW, Pye SR, Carter EL, Finn JD, Rutter MK, Laurent MR, Huhtaniemi IT, Han TS, Lean ME. Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men. The Journal of Clinical Endocrinology & Metabolism. 2015;100(4):1396-404. https://doi.org/10.1210/jc.2014-4184
30. Wang Q, Kangas AJ, Soininen P, Tiainen M, Tynkkynen T, Puukka K, Ruokonen A, Viikari J, Kähönen M, Lehtimäki T, Salomaa V. Sex hormone-binding globulin associations with circulating lipids and metabolites and the risk for type 2 diabetes: observational and causal effect estimates. International Journal of Epidemiology. 2015;44(2):623-37. https://doi.org/10.1093/ije/dyv093
31. Wittert G, Bracken K, Robledo KP, Grossmann M, Yeap BB, Handelsman DJ, Stuckey B, Conway A, Inder W, McLachlan R, Allan C. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. The lancet Diabetes & Endocrinology. 2021;9(1):32-45. https://doi.org/10.1016/s2213-8587(20)30367-3
32. Salminen M, Vahlberg T, Räihä I, Niskanen L, Kivelä SL, Irjala K. Sex hormones and the risk of type 2 diabetes mellitus: A 9‐year follow up among elderly men in F inland. Geriatrics & Gerontology International. 2015;15(5):559-64. https://doi.org/10.1111/ggi.12312
33. Ottarsdottir K, Hellgren M, Bock D, Nilsson AG, Daka B. Longitudinal associations between sex hormone-binding globulin and insulin resistance. Endocrine Connections. 2020;9(5):418-25. https://doi.org/10.1530/ec-20-0141
34. Ter Horst R, van den Munckhof IC, Schraa K, Aguirre-Gamboa R, Jaeger M, Smeekens SP, Brand T, Lemmers H, Dijkstra H, Galesloot TE, de Graaf J. Sex-specific regulation of inflammation and metabolic syndrome in obesity. Arteriosclerosis, Thrombosis, and Vascular Biology. 2020;40(7):1787-800. https://doi.org/10.1161/atvbaha.120.314508
35. Kurniawan LB, Adnan E, Mulyono B, Windarwati. Insulin resistance and testosterone level in Indonesian young adult males. Romanian Journal of Internal Medicine. 2020;58(2):93-8. https://doi.org/10.2478/rjim-2020-0004
36. Holota H, Thirouard L, Monrose M, Garcia M, De Haze A, Saru JP, Caira F, Beaudoin C, Volle DH. FXRα modulates leydig cell endocrine function in mouse. Molecular and Cellular Endocrinology. 2020;518:110995. https://doi.org/10.1016/j.mce.2020.110995
37. Gianatti EJ, Grossmann M. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment. Diabetic Medicine. 2020;37(2):174-86. https://doi.org/10.1111/dme.13977
38. Estoppey P, Clair C, Auderset D, Puder JJ. Sex differences in type 2 diabetes. Cardiovascular Medicine. 2023;26(3):96-9.  https://doi.org/10.4414/cvm.2023.02273
39. Emami MR, Safabakhsh M, Khorshidi M, Moghaddam OM, Mohammed SH, Zarezadeh M, Alizadeh S. Effect of bariatric surgery on endogenous sex hormones and sex hormone-binding globulin levels: a systematic review and meta-analysis. Surgery for Obesity and Related Diseases. 2021;17(9):1621-36. https://doi.org/10.1016/j.soard.2021.05.003
40. Zhang X, Mou Y, Aribas E, Amiri M, Nano J, Bramer WM, Kavousi M, de Knegt RJ, Asllanaj E, Ghanbari M. Associations of sex steroids and sex hormone-binding globulin with non-alcoholic fatty liver disease: a population-based study and meta-analysis. Genes. 2022 ;13(6):966. https://doi.org/10.3390/genes13060966
41. Simons PI, Valkenburg O, Stehouwer CD, Brouwers MC. Sex hormone–binding globulin: biomarker and hepatokine?. Trends in Endocrinology & Metabolism. 2021;32(8):544-53. https://doi.org/10.1016/j.tem.2021.05.002
42. Wan Q, Xie Y, Zhou Y, Shen X. Research progress on the relationship between sex hormone‐binding globulin and male reproductive system diseases. Andrologia. 2021;53(1):e13893. https://doi.org/10.1111/and.13893
43. Bourebaba N, Ngo T, Śmieszek A, Bourebaba L, Marycz K. Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment. Biomedicine & Pharmacotherapy. 2022;153:113261. https://doi.org/10.1016/j.biopha.2022.113261 
44. Huang R, Wang Y, Yan R, Ding B, Ma J. Sex hormone binding globulin is an independent predictor for insulin resistance in male patients with newly diagnosed type 2 diabetes mellitus. Diabetes Therapy. 2023;14(10):1627-37. https://doi.org/10.1007/s13300-023-01445-x
45. Mohammadrezaei A, Mokhtari Ardekani A, Abbasalizad-Farhangi M, Mesgari-Abbasi M, Mousavi R. Association between sex hormone-binding globulin, atherogenic indices of plasma among young sedentary males. Nutrition and Metabolic Insights. 2023;16:11786388231155006. https://doi.org/10.1177/11786388231155006
46. Smith SJ, Teo SYM, Lopresti AL, Heritage B, Fairchild TJ. Examining the effects of calorie restriction on testosterone concentrations in men: a systematic review and meta-analysis. Nutrition Reviews. 2022;80(5):1222-1236. https://doi.org/10.1093/nutrit/nuab072
47. Kovács G, Mohos E, Kis JT, Tabák Á, Gerendy P, Pettkó J, Nagy D, Győrbíró D, Kaló Z. Cost-Effectiveness of Bariatric Surgery in Patients Living with Obesity and Type 2 Diabetes. Journal of Diabetes Research. 2023:9686729.  https://doi.org/10.1155/2023/9686729